Adalimumab was an efficacious and safe treatment option for pediatric patients with moderate to severe ulcerative colitis, according to findings published in Lancet Gastroenteroly and Hepatology.

“Before the initiation of the present study in 2014, clinical trials in pediatric patients with moderate to severe ulcerative colitis were scarce,” Nicholas M. Croft, MD, PhD, MBBS, professor of pediatric gastroenterology at the Center for Immunology, Blizard Institute, Barts and London School of Medicine, Queen Mary University of London and the Royal London Children’s Hospital, and

Full Article: https://www.healio.com/news/gastroenterology/20210729/adalimumab-may-be-efficacious-safe-treatment-for-children-with-ulcerative-colitis